Cargando…
The effects of dopamine on digit span in Parkinson’s disease
BACKGROUND: Parkinson’s disease patients are at an elevated risk of developing cognitive impairment. Although cognitive impairment is one of the strongest predictors of quality of life, dopaminergic anti-parkinsonian medications are designed to target motor symptoms. However, there is substantial ev...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780147/ https://www.ncbi.nlm.nih.gov/pubmed/26955482 http://dx.doi.org/10.1186/s40734-016-0033-z |
_version_ | 1782419726166654976 |
---|---|
author | Warden, Clara Hwang, Jaclyn Marshall, Anisa Fenesy, Michelle Poston, Kathleen L. |
author_facet | Warden, Clara Hwang, Jaclyn Marshall, Anisa Fenesy, Michelle Poston, Kathleen L. |
author_sort | Warden, Clara |
collection | PubMed |
description | BACKGROUND: Parkinson’s disease patients are at an elevated risk of developing cognitive impairment. Although cognitive impairment is one of the strongest predictors of quality of life, dopaminergic anti-parkinsonian medications are designed to target motor symptoms. However, there is substantial evidence that dopamine also impacts cognition, in particular working memory. It is therefore critical for movement disorders physicians to understand the potential dopaminergic effects on working memory when prescribing these medications. Verbal digit span tasks offer a potentially straightforward and quick assessment of baseline working memory. Moreover, Digit Span Backward was recently validated as a screening tool for mild cognitive impairment in Parkinson’s disease when participants were medicated. Research indicates that the interaction between dopamine and working memory follows an Inverted-U shaped curve, but the effect of dopamine on Digit Span has not been well studied. Our study seeks to: (1) determine the validity of verbal Digit Spans for detecting cognitive impairment in Parkinson’s disease patients both ON and OFF medications; and (2) ascertain the effects of dopaminergic medications on verbal Digit Span. METHODS: We recruited 64 Parkinson’s disease patients and 22 age-and education-matched controls. Parkinson’s patients completed Digit Span Backward and Digit Span Forward ON and OFF medications, while healthy controls completed them once. All participants were categorized by cognitive diagnosis using level-II consensus criteria. RESULTS: Digit Span Backward successfully identified mild cognitive impairment in Parkinson’s disease, both ON and OFF medications. Combining patients with and without cognitive impairment, we found that dopamine significantly improved performance on Digit Span Backward, but not Forward. In a secondary analysis, we found this dopaminergic improvement was restricted to the Low baseline working memory group; the High baseline working memory group was unaffected. CONCLUSIONS: This study provides evidence for Digit Span Backward as a screening tool for working memory impairment in Parkinson’s disease and for its utility in measuring baseline working memory. Moreover, it reveals a partial beneficial effect of dopamine on Digit Span in Parkinson’s disease patients. |
format | Online Article Text |
id | pubmed-4780147 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47801472016-03-08 The effects of dopamine on digit span in Parkinson’s disease Warden, Clara Hwang, Jaclyn Marshall, Anisa Fenesy, Michelle Poston, Kathleen L. J Clin Mov Disord Research Article BACKGROUND: Parkinson’s disease patients are at an elevated risk of developing cognitive impairment. Although cognitive impairment is one of the strongest predictors of quality of life, dopaminergic anti-parkinsonian medications are designed to target motor symptoms. However, there is substantial evidence that dopamine also impacts cognition, in particular working memory. It is therefore critical for movement disorders physicians to understand the potential dopaminergic effects on working memory when prescribing these medications. Verbal digit span tasks offer a potentially straightforward and quick assessment of baseline working memory. Moreover, Digit Span Backward was recently validated as a screening tool for mild cognitive impairment in Parkinson’s disease when participants were medicated. Research indicates that the interaction between dopamine and working memory follows an Inverted-U shaped curve, but the effect of dopamine on Digit Span has not been well studied. Our study seeks to: (1) determine the validity of verbal Digit Spans for detecting cognitive impairment in Parkinson’s disease patients both ON and OFF medications; and (2) ascertain the effects of dopaminergic medications on verbal Digit Span. METHODS: We recruited 64 Parkinson’s disease patients and 22 age-and education-matched controls. Parkinson’s patients completed Digit Span Backward and Digit Span Forward ON and OFF medications, while healthy controls completed them once. All participants were categorized by cognitive diagnosis using level-II consensus criteria. RESULTS: Digit Span Backward successfully identified mild cognitive impairment in Parkinson’s disease, both ON and OFF medications. Combining patients with and without cognitive impairment, we found that dopamine significantly improved performance on Digit Span Backward, but not Forward. In a secondary analysis, we found this dopaminergic improvement was restricted to the Low baseline working memory group; the High baseline working memory group was unaffected. CONCLUSIONS: This study provides evidence for Digit Span Backward as a screening tool for working memory impairment in Parkinson’s disease and for its utility in measuring baseline working memory. Moreover, it reveals a partial beneficial effect of dopamine on Digit Span in Parkinson’s disease patients. BioMed Central 2016-03-07 /pmc/articles/PMC4780147/ /pubmed/26955482 http://dx.doi.org/10.1186/s40734-016-0033-z Text en © Warden et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Warden, Clara Hwang, Jaclyn Marshall, Anisa Fenesy, Michelle Poston, Kathleen L. The effects of dopamine on digit span in Parkinson’s disease |
title | The effects of dopamine on digit span in Parkinson’s disease |
title_full | The effects of dopamine on digit span in Parkinson’s disease |
title_fullStr | The effects of dopamine on digit span in Parkinson’s disease |
title_full_unstemmed | The effects of dopamine on digit span in Parkinson’s disease |
title_short | The effects of dopamine on digit span in Parkinson’s disease |
title_sort | effects of dopamine on digit span in parkinson’s disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780147/ https://www.ncbi.nlm.nih.gov/pubmed/26955482 http://dx.doi.org/10.1186/s40734-016-0033-z |
work_keys_str_mv | AT wardenclara theeffectsofdopamineondigitspaninparkinsonsdisease AT hwangjaclyn theeffectsofdopamineondigitspaninparkinsonsdisease AT marshallanisa theeffectsofdopamineondigitspaninparkinsonsdisease AT fenesymichelle theeffectsofdopamineondigitspaninparkinsonsdisease AT postonkathleenl theeffectsofdopamineondigitspaninparkinsonsdisease AT wardenclara effectsofdopamineondigitspaninparkinsonsdisease AT hwangjaclyn effectsofdopamineondigitspaninparkinsonsdisease AT marshallanisa effectsofdopamineondigitspaninparkinsonsdisease AT fenesymichelle effectsofdopamineondigitspaninparkinsonsdisease AT postonkathleenl effectsofdopamineondigitspaninparkinsonsdisease |